<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    4817186
   </pmid>
   <datecreated>
    <year>
     1974
    </year>
    <month>
     05
    </month>
    <day>
     17
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1974
    </year>
    <month>
     05
    </month>
    <day>
     17
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2010
    </year>
    <month>
     10
    </month>
    <day>
     26
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0007-1447
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       1
      </volume>
      <issue>
       5907
      </issue>
      <pubdate>
       <year>
        1974
       </year>
       <month>
        Mar
       </month>
       <day>
        23
       </day>
      </pubdate>
     </journalissue>
     <title>
      British medical journal
     </title>
     <isoabbreviation>
      Br Med J
     </isoabbreviation>
    </journal>
    <articletitle>
     Blood pressure in women taking oral contraceptives.
    </articletitle>
    <pagination>
     <medlinepgn>
      533-5
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      A controlled prospective survey of women taking oestrogen-progestogen oral contraceptives showed increases in mean systolic and diastolic blood pressure of 14.2 mm Hg and 8.5 mm Hg respectively after four years. The largest increases in individual cases were 36 mm Hg systolic and 20 mm Hg diastolic. Blood pressure returned to pretreatment levels within three months after oral contraceptives had been stopped. These changes in blood pressure were unrelated to the progestogenic potencies of the preparations being taken.
     </abstracttext>
    </abstract>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Weir
      </lastname>
      <forename>
       R J
      </forename>
      <initials>
       RJ
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Briggs
      </lastname>
      <forename>
       E
      </forename>
      <initials>
       E
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Mack
      </lastname>
      <forename>
       A
      </forename>
      <initials>
       A
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Naismith
      </lastname>
      <forename>
       L
      </forename>
      <initials>
       L
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Taylor
      </lastname>
      <forename>
       L
      </forename>
      <initials>
       L
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Wilson
      </lastname>
      <forename>
       E
      </forename>
      <initials>
       E
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     Br Med J
    </medlineta>
    <nlmuniqueid>
     0372673
    </nlmuniqueid>
    <issnlinking>
     0007-1447
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Contraceptives, Oral
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      3562-63-8
     </registrynumber>
     <nameofsubstance>
      Megestrol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      52-76-6
     </registrynumber>
     <nameofsubstance>
      Lynestrenol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      57-63-6
     </registrynumber>
     <nameofsubstance>
      Ethinyl Estradiol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      68-22-4
     </registrynumber>
     <nameofsubstance>
      Norethindrone
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      72-33-3
     </registrynumber>
     <nameofsubstance>
      Mestranol
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Obstet Gynecol. 1972 Apr 1;112(7):912-9
     </refsource>
     <pmid version="1">
      4114467
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Obstet Gynecol. 1970 Mar;35(3):371-6
     </refsource>
     <pmid version="1">
      4190423
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 1971 Jan;74(1):13-21
     </refsource>
     <pmid version="1">
      4321709
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Intern Med. 1970 Oct;126(4):621-6
     </refsource>
     <pmid version="1">
      4319180
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Obstet Gynaecol Br Commonw. 1970 Nov;77(11):1007-12
     </refsource>
     <pmid version="1">
      4320691
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Heart J. 1972 Dec;34(12):1238-43
     </refsource>
     <pmid version="1">
      4647097
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Aust N Z J Obstet Gynaecol. 1971 Aug;11(3):148-56
     </refsource>
     <pmid version="1">
      5286756
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Cardiol. 1971 Apr;27(4):335-46
     </refsource>
     <pmid version="1">
      5572576
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Obstet Gynaecol Br Commonw. 1970 Apr;77(4):349-55
     </refsource>
     <pmid version="1">
      5427298
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Blood Pressure
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Body Weight
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Contraceptive Devices
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Contraceptives, Oral
     </descriptorname>
     <qualifiername majortopicyn="Y">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ethinyl Estradiol
     </descriptorname>
     <qualifiername majortopicyn="N">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Devices
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Lynestrenol
     </descriptorname>
     <qualifiername majortopicyn="N">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Megestrol
     </descriptorname>
     <qualifiername majortopicyn="N">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Mestranol
     </descriptorname>
     <qualifiername majortopicyn="N">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Norethindrone
     </descriptorname>
     <qualifiername majortopicyn="N">
      pharmacology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Time Factors
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1633638
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1974
     </year>
     <month>
      3
     </month>
     <day>
      23
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1974
     </year>
     <month>
      3
     </month>
     <day>
      23
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1974
     </year>
     <month>
      3
     </month>
     <day>
      23
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     4817186
    </articleid>
    <articleid idtype="pmc">
     PMC1633638
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

